150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse

Pharmacological Research

Volumn 51, Issue 5, 2005, Pages 399-408

  Lee, Sei Jung ^a   Ko, Jeong Hyeon ^a   Lim, Kwang ^b   Lim, Kye Taek ^a  

^a Chonnam National University   (South Korea)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Detoxicant enzymes; Glycoprotein; HMG CoA reductase; Hypolipidemic activity; Solanum nigrum Linne

Indexed keywords

CATALASE; CHOLESTEROL; COLESTYRAMINE; CORN OIL; GLUTATHIONE PEROXIDASE; GLYCOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TYLOXAPOL; VEGETABLE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME INHIBITION; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SOLANUM NIGRUM; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 14644399259     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2004.11.004     Document Type: Article

References (49)

1. J.J. Badimon, V. Fuster, J.H. Chesebro, and L. Badimon Coronary atherosclerosis A multifactorial disease Circulation 87 1993 3 16
2. F. Bracco, M. Scarpa, A. Rigo, and L. Battistin Determination of superoxide dismutase activity by the polarographic method of catalytic currents in the cerebrospinal fluid of aging brain and neurologic degenerative diseases Proc Soc Exp Biol Med 196 1991 36 41
3. J.L. Goldstein, H.G. Schrott, W.R. Hazzard, E.L. Bierman, and A.G. Motulsky Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia J Clin Invest 52 1973 1544 1568
4. F.B. Araujo, D.S. Barbosa, C.Y. Hsin, R.C. Maranhao, and D.S. Abdalla Evaluation of oxidative stress in patients with hyperlipidemia Atherosclerosis 117 1995 61 71
5. D.L. Nelson, and M.M. Cox Lehninger principles of biochemistry 3rd ed. 2000 Worth Publishers New York p. 804-9
6. W.H. Ellott, and D.C. Ellott Biochemistry and molecular biology 1997 Oxford University Press Inc. New York p. 88-91
7. J.L. Goldstein, and M.S. Brown Regulation of the mevalonate pathway Nature 343 1990 425 430
8. M. Nakanishi, J.L. Goldstein, and M.S. Brown Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme J Biol Chem 263 1988 8929 8937
9. S.M. Grundy, E.H. Ahrens Jr., and G. Salen Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism J Lab Clin Med 78 1971 94 121
10. V.E. Ooi, and F. Liu Immunomodulation and anti-cancer activity of polysaccharide-protein complexes Curr Med Chem 7 2000 715 729
11. M. Zhou, Y. Chen, Q. Ouyang, S.X. Liu, and Z.J. Pang Reduction of the oxidative injury to the rabbits with established atherosclerosis by protein bound polysaccharide from Coriolus vesicolor Am J Chin Med 28 2000 239 249
12. C. Yuan, Z. Mei, S. Liu, and L. Yi PSK protects macrophages from lipoperoxide accumulation and foam cell formation caused by oxidatively modified low-density lipoprotein Atherosclerosis 124 1996 171 181
13. S.J. Lee, and K.T. Lim Anti-oxidative effects of glycoprotein isolated from Solanum nigrum Linne on oxygen radicals and its cytotoxic effects on the MCF-7 cells J Food Sci 68 2003 466 470
14. K.S. Heo, S.J. Lee, and K.T. Lim Cytotoxic effect of glycoprotein isolated from Solanum nigrum L. through the inhibition of hydroxyl radical-induced DNA-binding activities of NF-kappa B in HT-29 cells Environ Toxicol Pharmacol 17 2004 45 54
15. K.T. Lim, K.S. Heo, and Y.O. Son Antioxidative and antimicrobial effects of glycoprotein isolated from Solanum nigrum Linne Food Sci Biotechnol 11 2002 484 489
16. A. Tasinato, D. Boscoboinik, G.M. Bartoli, P. Maroni, and A. Azzi d-Alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties Proc Natl Acad Sci USA 92 1995 12190 12194
17. D.M. Neville, and H. Glossmann Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate Methods Enzymol 32 1974 92 102
18. S.J. Lee, K.S. Heo, P.S. Oh, K. Lim, and K.T. Lim Glycoprotein isolated from Ulmus davidiana Nakai inhibits TPA-induced apoptosis through nuclear factor-kappa B in NIH/3T3 cells Toxicol Lett 146 2004 159 174
19. T. Takao, F. Kitatani, N. Watanabe, A. Yagi, and K. Sakata A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish Biosci Biotechnol Biochem 58 1994 1780 1783
20. American Society of Mammalogists Animal Care and Use Committee. Guidelines for the capture, handling, and care of mammals as approved by the American Society of Mammalogists. J Mammal 1998;79:1416-31.
21. H. Kusama, M. Nishiyama, and S. Ikeda Pharmacological investigation of bezafibrate, a hypolipidemic agent 1. Effects of bezafibrate on normal and experimental hyperlipidemia in rats Nippon Yakurigaku Zasshi 92 1988 175 180
22. J. Duhault, M. Boulanger, L. Beregi, N. Sicot, and F. Bouvier 780 SE: a new type of hypolipemic agent Comparative assays in rats Atherosclerosis 23 1976 63 72
23. 2+ precipitation procedure for quantitation of high-density- lipoprotein cholesterol Clin Chem 28 1982 1379 1388
24. R.W. Burke, B.I. Diamondstone, R.A. Velapoldi, and O. Menis Mechanisms of the Liebermann-Burchard and Zak color reactions for cholesterol Clin Chem 20 1974 781 794
25. A.M. Tercyak Determination of cholesterol and cholesterol esters J Nutr Biochem. 2 1991 281 292
26. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J Biol Chem 193 1951 265 275
27. C. Beauchamp, and I. Fridovich Superoxide dismutase: improved assays and an assay applicable to acrylamide gels Anal Biochem 44 1971 276 287
28. J.F. Thomson, S.L. Nance, and S.L. Tollaksen Spectrophotometric assay of catalase with perborate as substrate Proc Soc Exp Biol Med 157 1978 33 35
29. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathine peroxidase J Lab Clin Med 70 1967 158 169
30. P.A. Edwards, D. Lemongello, and A.M. Fogelman Improved methods for the solubilization and assay of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase J Lipid Res 20 1979 40 46
31. I. Jialal, and C.J. Fuller Oxidized LDL and antioxidants Clin Cardiol 16 1993 6 9
32. S. Sultana, S. Perwaiz, M. Iqbal, and M. Athar Crude extracts of hepatoprotective plants, Solanum nigrum and Cichorium intybus inhibit free radical-mediated DNA damage J Ethnopharmacol 45 1995 189 192
33. R.M. Perez, J.A. Perez, L.M. Garcia, and H. Sossa Neuropharmacological activity of Solanum nigrum fruit J Ethnopharmacol 62 1998 43 48
34. V. Prashanth Kumar, S. Shashidhara, M.M. Kumar, and B.Y. Sridhara Cytoprotective role of Solanum nigrum against gentamicin-induced kidney cell (Vero cells) damage in vitro Fitoterapia 72 2001 481 486
35. T. Chan, G. Galati, and P.J. O'Brien Oxygen activation during peroxidase catalysed metabolism of flavones or flavanones Chem Biol Interact 122 1999 15 25
36. J. Regnstrom, J. Nilsson, P. Tornvall, C. Landou, and A. Hamsten Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man Lancet 339 1992 1183 1186
37. M. Friedman, and S.O. Byers The mechanism responsible for the hypercholesteremia induced by triton WR-1339 J Exp Med 97 1953 117 130
38. R.L. Hirsch, and A. Kellner The pathogenesis of hyperlipemia induced by means of surface-active agents I. Increased total body cholesterol in mice given triton WR 1339 parenterally J Exp Med 104 1956 1 13
39. R.L. Hirsch, and A. Kellner The pathogenesis of hyperlipemia induced by means of surface-active agents II. Failure of exchange of cholesterol between the plasma and the liver in rabbits given triton WR 1339 J Exp Med 104 1956 15 24
40. T. Toda, and H. Oku Effect of medium-chain fatty acids on cholesterolemia and atherosclerosis in Japanese quails Nutr Res 15 1995 99 113
41. K.M. West, M.M. Ahuja, P.H. Bennett, A. Czyzyk, O.M. De Acosta, and J.H. Fuller The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study Diabetes Care 6 1983 361 369
42. C. Moundras, S.R. Behr, C. Demigne, A. Mazur, and C. Remesy Fermentable polysaccharides that enhance fecal bile acid excretion lower plasma cholesterol and apolipoprotein E-rich HDL in rats J Nutr 124 1994 2179 2188
43. T.M. Wolever, D.J. Jenkins, R. Nineham, and K.G. Alberti Guar gum and reduction of post-prandial glycaemia: effect of incorporation into solid food, liquid food, and both Br J Nutr 41 1979 505 510
44. E.R. Stedronsky Interaction of bile acids and cholesterol with non-systemic agents having hypocholesterolemic properties Biochim Biophys Acta 1210 1994 255 287
45. R. Feachem Health decline in eastern Europe Nature 367 1994 313 314
46. J.L. Witztum The oxidation hypothesis of atherosclerosis Lancet 344 1994 793 795
47. H. Ishii, T. Suga, H. Hayashi, and S. Niinobe Effect of triton WR-1339 on peroxisomal enzymes of rat liver Biochim Biophys Acta 582 1979 213 220
48. H. Ishii, T. Suga, H. Hayashi, and S. Niinobe Effect of Triton WR-1339 on the rates of synthesis and degradation of hepatic catalase of rat J Biochem 86 1979 1163 1166
49. D.R. Illingworth Lipid-lowering drugs An overview of indications and optimum therapeutic use Drugs 33 1987 259 279